These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26481283)

  • 1. Discussion.
    Pham SM
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):496. PubMed ID: 26481283
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel effect of rapamycin on experimental obliterative bronchiolitis.
    Walters DM; Mulligan MS
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):317-8. PubMed ID: 26806507
    [No Abstract]   [Full Text] [Related]  

  • 3. Harnessing regulatory B cells to prevent experimental obliterative bronchiolitis.
    Jungraithmayr W; Brüstle K; Weder W
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):497-8. PubMed ID: 26520010
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapamycin prevents bronchiolitis obliterans through increasing infiltration of regulatory B cells in a murine tracheal transplantation model.
    Zhao Y; Gillen JR; Meher AK; Burns JA; Kron IL; Lau CL
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):487-96.e3. PubMed ID: 26481278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: leukocyte trafficking and matrix metalloproteinase-8 in obliterative bronchiolitis.
    Grasemann H; Ratjen F
    J Leukoc Biol; 2010 Jan; 87(1):23-4. PubMed ID: 20047888
    [No Abstract]   [Full Text] [Related]  

  • 6. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor.
    al-Dossari GA; Jessurun J; Bolman RM; Kshettry VR; King MB; Murray JJ; Hertz MI
    Transplantation; 1995 Jan; 59(1):143-5. PubMed ID: 7839417
    [No Abstract]   [Full Text] [Related]  

  • 8. Invited commentary.
    van der Kaaij NP; Bogers AJ
    Ann Thorac Surg; 2006 Sep; 82(3):1050-1. PubMed ID: 16928533
    [No Abstract]   [Full Text] [Related]  

  • 9. CD28 superagonist antibody treatment attenuated obliterative bronchiolitis in rat allo-orthotopic tracheal transplantation by preferentially expanding Foxp3-expressing regulatory T cells.
    Shi Q; Niu Y; Cao H; Zhou X; Jiang S; Liu Z; Fan H
    Transplant Proc; 2012 May; 44(4):1060-6. PubMed ID: 22564625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ Foxp3+ regulatory T cells induced by TGF-β, IL-2 and all-trans retinoic acid attenuate obliterative bronchiolitis in rat trachea transplantation.
    Shi Q; Cao H; Liu J; Zhou X; Lan Q; Zheng S; Liu Z; Li Q; Fan H
    Int Immunopharmacol; 2011 Nov; 11(11):1887-94. PubMed ID: 21839859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
    Reichenspurner H; Adams B; Soni V; Brazelton T; Shorthouse R; Reitz BA; Berry GJ; Morris RE
    Transplant Proc; 1996 Apr; 28(2):729-30. PubMed ID: 8623368
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas.
    Qu N; de Vos P; Schelfhorst M; de Haan A; Timens W; Prop J
    J Heart Lung Transplant; 2005 Jul; 24(7):882-90. PubMed ID: 15982618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
    Watanabe T; Okada Y; Hoshikawa Y; Eba S; Notsuda H; Watanabe Y; Ohishi H; Sato Y; Kondo T
    Transplant Proc; 2012 May; 44(4):1155-7. PubMed ID: 22564651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory actions of tanshinone leukocyte chemotaxis].
    Gao JY
    Zhong Xi Yi Jie He Za Zhi; 1985 Nov; 5(11):684-5, 645. PubMed ID: 2938814
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties.
    Kwak BR; Mach F
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1256-8. PubMed ID: 11498448
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting effect of non-steroidal anti-inflammatory drugs on the chemotaxis of human leukocytes in vitro.
    Magliulo E; Benzi-Cipelli R; Lago A; Azzini M; Magni E; Gallico S; Sacchetti G
    Int J Clin Pharmacol Biopharm; 1977 Sep; 15(9):417-8. PubMed ID: 72047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invited commentary.
    Bhorade S
    Ann Thorac Surg; 2014 Jan; 97(1):274-5. PubMed ID: 24384177
    [No Abstract]   [Full Text] [Related]  

  • 20. Repeated systemic administration of adipose tissue-derived mesenchymal stem cells prevents tracheal obliteration in a murine model of bronchiolitis obliterans.
    Lorenzi W; Gonçalves FDC; Schneider N; Silva ÉF; Visioli F; Paz AH; Saueressig MG
    Biotechnol Lett; 2017 Aug; 39(8):1269-1277. PubMed ID: 28528427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.